Clinical Trials Browser

Withdrawn × Raloxifene Hydrochloride × Clear all

NCT03147196 2019-01-22

Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Phase 2 Withdrawn

Stage I Prostate Adenocarcinoma